Introduction: The End of the Binary Debate
Few issues generate more heat in contemporary medicine than scope of practice. Physicians describe “scope creep” as the expansion of clinical duties to nonphysicians, and they view it as a threat to patient safety, professional identity, and clinical rigor. Advocates of expanded scope emphasize access, efficiency, and workforce shortages. The debate often is adversarial, emotionally charged, and rhetorically absolutist.
Yet this binary framing — competition versus collaboration — no longer reflects how healthcare actually functions. Hospitals, health systems, and outpatient networks now operate in environments characterized by workforce scarcity, escalating costs, regulatory pressure, and rising clinical complexity. Under these conditions, pure competition is unsustainable, and pure cooperation is unrealistic. What has emerged instead is “coopetition”: the simultaneous presence of collaboration and competition among overlapping professional roles and responsibilities.
Healthcare organizations increasingly share personnel, redistribute responsibilities, and blend scopes of practice — sometimes deliberately, sometimes by default. Whether these arrangements strengthen care delivery or undermine it depends less on ideology than on leadership. For physician leaders, the question is no longer whether scope overlap will expand, it is whether it will be designed with intent or left to drift.
Why Coopetition Has Become Inevitable in Healthcare
Coopetition arises when organizations or professionals face challenges that cannot be solved independently. In healthcare, those challenges are structural and persistent: workforce shortages; capital intensity; rising demand; and regulatory complexity.
Recent health policy scholarship identifies coopetition as a rational response to these pressures, particularly in sectors requiring expensive technology, specialized expertise, and coordinated care pathways.(1) Hospitals may share infrastructure while competing for patients. Pharmaceutical firms may collaborate on research while competing commercially. Clinical professionals may overlap in function while retaining distinct domains of authority.
Importantly, coopetition is not a compromise born of goodwill. It is a strategy born of constraint. However, coopetition also is unstable. Without explicit governance, it can degrade into role confusion, mistrust, and covert substitution, especially when financial incentives reward cost minimization more than clinical quality.
What Is at Stake: Beyond Turf Wars
Patient Safety and Clinical Accountability
What remains unresolved is not whether coopetition will occur, but what happens when it is poorly governed. The highest stakes are clinical. Scope overlap that lacks clear escalation pathways, diagnostic authority, and accountability structures increases the risk of fragmented care. When “everyone can do a little of everything,” responsibility for treatment and adverse outcomes becomes diffuse.
Empirical evidence underscores this risk. In Florida, nurse practitioners who were granted unsupervised practice authority in primary care were later found, in substantial numbers, to be practicing in non–primary care specialties — including psychiatry, inpatient medicine, and cosmetic services — despite statutory restrictions.(2) The issue was not scope expansion per se, but the absence of enforcement and governance.
Professional Integrity and Liability
For physicians, unmanaged scope overlap threatens more than income or prestige. It undermines professional identity and moral coherence. Physicians are increasingly asked to “supervise” care without genuine authority, or to accept clinical responsibility without control over decision-making. This asymmetry fuels moral injury: physicians remain accountable for outcomes while losing influence over processes. In states that require formal collaboration agreements, physicians may remain liable for the acts of advanced practice providers (APPs) under vicarious liability and negligent supervision theories. This exposure can persist even when APPs function with substantial autonomy.
System Trust and Regulatory Credibility
When laws governing scope are enforced inconsistently or ignored, public trust erodes. Patients cannot meaningfully consent to care when distinctions in training and authority are obscured. Regulators lose credibility. Organizations substitute expediency for transparency. In such environments, coopetition becomes a rhetorical cover for deregulated substitution rather than a disciplined strategy.
Effective coopetition depends on understanding where roles genuinely differ. Table 1 summarizes key distinctions in education, clinical exposure, and training across physician and commonly overlapping nonphysician roles, highlighting why governance and escalation pathways matter. These differences do not preclude collaboration, but they underscore why role interchangeability without governance is a leadership choice rather than a neutral operational adjustment.
Winners and Losers in an Era of Scope Overlap
In an era of expanding scope overlap, the distribution of benefits and burdens is uneven. Large integrated health systems are positioned to benefit most, as they gain workforce flexibility, leverage economies of scale, and deploy blended clinical teams while absorbing financial and reputational risk. Payers and purchasers likewise stand to gain, because broader provider categories increase negotiating leverage and facilitate cost-containment strategies. Some nonphysician clinicians also may benefit when expanded responsibilities are clearly defined, well governed, and meaningfully integrated into team-based care, enhancing both professional fulfillment and patient access.
In contrast, independent and small-group physicians, particularly those in cognitive specialties where diagnostic depth is central but reimbursement remains limited, are disproportionately disadvantaged. Patients with complex, atypical, or diagnostically challenging conditions are especially vulnerable, because shallow expertise and fragmented accountability undermine continuity and safety. Ultimately, the profession of medicine itself is at risk when distinctions grounded in training, epistemology, and clinical responsibility are recast as obstruction rather than value, threatening to reduce medicine from a learned profession to a generic service industry.
When Coopetition Works: Conditions for Success
Healthcare research identifies multiple forms of coopetition, with outcomes that vary dramatically depending on how overlap is structured and governed.(3) The most successful arrangements are grounded in complementarity rather than substitution, relying on interdependence instead of interchangeability. In these models, roles are distinct but coordinated, as seen in anesthesiology care teams where anesthesiologists and nurse anesthetists (CRNAs) operate within a clearly defined hierarchy of escalation and responsibility. The objective is not replacement, but capacity amplification.
Equally essential is explicit governance. Effective coopetition requires clear delineation of decision authority, well-defined escalation thresholds, and transparent ownership of clinical outcomes. In the absence of these safeguards, collaboration devolves into substitution, eroding accountability and trust. Finally, successful coopetition depends on a shared ethical orientation. In settings where patient-centered value creation is explicit, such as oncology networks and integrated care pathways, clinicians are more willing to tolerate tension and complexity because the purpose of collaboration is legitimate, visible, and aligned with professional values.
When Coopetition Fails: Predictable Fault Lines
Coopetition predictably fails along several well-defined fault lines. Psychiatry and behavioral health represent particularly high-risk domains for horizontal overlap, as diagnostic complexity, longitudinal therapeutic relationships, and psychopharmacologic management require deep and integrated training. When role overlap occurs without a shared theory of knowledge, robust supervision, or clear escalation pathways, clinical outcomes and continuity of care are compromised.
Similar risks are evident in retail and commercialized medicine, where overlaps between physicians and pharmacists or naturopaths often reflect market competition rather than true clinical collaboration. In these settings, coopetition functions less as a partnership for patient care and more as a veneer for service expansion. Cosmetic and socalled “wellness” medicine further highlight these concerns. In autonomous practice environments, scope drift combined with weak regulatory enforcement allows expansion to slide into exploitation, eroding professional standards and public trust.
Leadership Considerations for Managing Scope Overlap
Physician leaders should evaluate scope expansion initiatives using four core questions:
Is role overlap complementary or substitutive?
Who retains diagnostic authority and escalation responsibility?
Who is accountable when outcomes are poor? and
Are patients being given clear, accurate, and non-misleading information about the training, credentials, and authority of those providing their care?
This final question is not merely about patient understanding, but about transparency and trust. When distinctions are blurred through titles, badges, or organizational messaging that obscure professional differences, the issue is no longer collaboration but misrepresentation. If these questions cannot be answered clearly and honestly, coopetition has already failed.
Portents for Physician Leaders
Several portents should command the immediate attention of physician leaders. Scope overlap introduced without explicit governance is not innovation but abdication, and cost savings achieved through ambiguity are rarely durable, often repaid later in the form of quality failures, safety events, and loss of trust. Professional harmony does not arise from flattening meaningful differences in training or responsibility, but from respecting them and designing roles that are complementary rather than interchangeable. Increasingly, effective physician leadership is defined less by boundary defense than by intentional boundary setting — clarifying authority, accountability, and escalation before conflict arises.
The future of medicine ultimately will hinge on whether leaders actively design and govern coopetition or allow unmanaged drift to make those decisions by default. Coopetition is not a peace treaty; it is a disciplined, sometimes uncomfortable, and ethically demanding strategy. When governed well, it can expand access while preserving excellence. When governed poorly, however, it accelerates the erosion of trust, accountability, and professional meaning. The choice before physician leaders is not whether scope overlap will continue, but whether medicine will remain a profession defined by intentional stewardship or devolve into a marketplace governed by silent substitution.
References
Sadeqi-Arani Z, Mazroui Nasrabadi E. Coopetition strategy in the healthcare: good or bad? Int J Health Policy Manag. 2024;13:8679. https://doi.org/10.34172/ijhpm.8679 .
Bernard R, Shaffer PB, D’Souza SL, et al. Autonomous nurse practitioners in Florida frequently practice outside their legal scope of primary care: a cross-sectional study, Family Practice. 2026;43(1):cmaf104. https://doi.org/10.1093/fampra/cmaf104 .
Albert-Cromarias A, Dos Santos C. Coopetition in healthcare: heresy or reality? An exploration of felt outcomes at an intra-organizational level. Social Science & Medicine. 2020;252:112938. https://doi.org/10.1016/j.socscimed.2020.112938 .